Literature DB >> 22612505

Development of ulcerative colitis and its associated colorectal neoplasia as a model of the organ-specific chronic inflammation-carcinoma sequence.

Isao Okayasu1.   

Abstract

The organ-specific chronic inflammation-carcinoma sequence was summarized and proposed. As a typical model, the ulcerative colitis (UC)--UC-associated carcinoma sequence was selected, and the mechanism of development of UC and UC-associated carcinoma was reviewed, referring mainly to our data. Intestinal commensal bacteria, including Fusobacterium varium, obtained from the colonic mucosa of UC patients, can enter colonic epithelia and induce secretion of inflammatory cytokines, resulting in early inflammatory lesions consisting of cryptitis and crypt abscess. Inflammatory oxidative stress causes epithelial cell DNA-damage followed by p53 dependent G1 checkpoint activation and overloading, which causes p53 mutation. In long-standing UC, mucosal remodeling, including possible loss of crosstalk between epithelium and stroma may be critical for the development of UC-associated carcinoma, as well as accumulation of early p53 mutation at the crypt level and increase of other stem cell mutated crypts, telomere shortening, and genomic instability of epithelial and stromal cells, including subepithelial myofibroblasts (corresponding to colonic stellate cells or Ito cells) and interstitial cells. Thus, the stochastic (probabilistic) pathway to tumor development over time gains commonalty through chronic inflammation stimulation. For the prevention of cancer development, appropriate anti-inflammatory therapy is important with an accurate assessment of the inflammation status in the colorectum.
© 2012 The Author. Pathology International © 2012 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22612505     DOI: 10.1111/j.1440-1827.2012.02807.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  19 in total

1.  Costus root granules improve ulcerative colitis through regulation of TGF-β mediation of the PI3K/AKT signaling pathway.

Authors:  Xiaohong Wang; Dan Li; Yong Zhang; Shuang Wu; Fang Tang
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

Review 2.  The contribution of neuronal-glial-endothelial-epithelial interactions to colon carcinogenesis.

Authors:  Sergio Britto Garcia; Helga Stopper; Vinicius Kannen
Journal:  Cell Mol Life Sci       Date:  2014-05-22       Impact factor: 9.261

3.  A case of primary colonic small-cell carcinoma arising in a patient with long-standing ulcerative colitis.

Authors:  Renée M Marchioni Beery; Thomas J Devers; Jessica M Clement
Journal:  Gastrointest Cancer Res       Date:  2014-05

Review 4.  Microbiota impact on the epigenetic regulation of colorectal cancer.

Authors:  Tao Yang; Jennifer L Owen; Yaíma L Lightfoot; Michael P Kladde; Mansour Mohamadzadeh
Journal:  Trends Mol Med       Date:  2013-09-16       Impact factor: 11.951

5.  Activation of intestinal human pregnane X receptor protects against azoxymethane/dextran sulfate sodium-induced colon cancer.

Authors:  Jie Cheng; Zhong-Ze Fang; Kenjiro Nagaoka; Minoru Okamoto; Aijuan Qu; Naoki Tanaka; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2014-10-02       Impact factor: 4.030

6.  Cell injury and repair resulting from sleep loss and sleep recovery in laboratory rats.

Authors:  Carol A Everson; Christopher J Henchen; Aniko Szabo; Neil Hogg
Journal:  Sleep       Date:  2014-12-01       Impact factor: 5.849

7.  Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal Intestine.

Authors:  Pinelopi Nterma; Eleni Panopoulou; Eleni Papadaki-Petrou; Martha Assimakopoulou
Journal:  Pathol Oncol Res       Date:  2019-01-02       Impact factor: 3.201

8.  Layered signaling regulatory networks analysis of gene expression involved in malignant tumorigenesis of non-resolving ulcerative colitis via integration of cross-study microarray profiles.

Authors:  Shengjun Fan; Zhenyu Pan; Qiang Geng; Xin Li; Yefan Wang; Yu An; Yan Xu; Lu Tie; Yan Pan; Xuejun Li
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

9.  Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.

Authors:  Shigeo Koido; Toshifumi Ohkusa; Takayuki Kajiura; Junko Shinozaki; Manabu Suzuki; Keisuke Saito; Kazuki Takakura; Shintaro Tsukinaga; Shunichi Odahara; Toyokazu Yukawa; Jimi Mitobe; Mikio Kajihara; Kan Uchiyama; Hiroshi Arakawa; Hisao Tajiri
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

10.  Iron-ascorbate-mediated lipid peroxidation causes epigenetic changes in the antioxidant defense in intestinal epithelial cells: impact on inflammation.

Authors:  Sabrina Yara; Jean-Claude Lavoie; Jean-François Beaulieu; Edgard Delvin; Devendra Amre; Valerie Marcil; Ernest Seidman; Emile Levy
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.